Long-term remission of chronic-type adult T-cell leukemia/lymphoma associated with Graves' disease treated with methimazole [0.03%]
甲巯咪唑治疗与Graves病相关的慢性成人T细胞白血病/淋巴瘤长期缓解的病例报告
Shigeo Fuji,Kako Suzuki,Eri Watanabe et al.
Shigeo Fuji et al.
Adult T-cell leukemia/lymphoma (ATL) is a rare T-cell malignancy, where the chronic type often progresses to an acute form in the presence of poor prognostic factors. We report a remarkable case of chronic-type ATL that achieved long-term h...
Comparison of Pola-R-CHP and R-CHOP for newly diagnosed DLBCL: A single-center retrospective study [0.03%]
帕芦溴弹药方案与R-CHOP治疗初治DLBCL患者的疗效比较——单中心回顾性研究
Kaori Akita,Atsushi Takahata,Wataru Tokuyama et al.
Kaori Akita et al.
Background Polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone (Pola-R-CHP) has become a first-line treatment option for diffuse large B-cell lymphoma (DLBCL), but real-world data remain limited. We retrospec...
A case of bone marrow-liver-spleen type diffuse large B-cell lymphoma: importance of rapid diagnosis and therapeutic intervention [0.03%]
骨髓肝脾型弥漫大B细胞淋巴瘤一例及诊治体会
Hitomi Eda,Kaoru Furihata,Fumiya Ogasawara
Hitomi Eda
Bone marrow-liver-spleen (BLS)-type diffuse large B-cell lymphoma (DLBCL) is a rare and aggressive variant characterized by primary involvement of the bone marrow, liver, and spleen without lymphadenopathy. We describe the case of a 73-year...
Real-world comparison of brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone and anthracycline-based regimens in peripheral T-cell lymphoma: A multicenter retrospective study from the Gifu Hematology Study Group [0.03%]
Brentuximab Vedotin联合环磷酰胺、多柔比星和泼尼松与蒽环类药物为基础的方案治疗外周T细胞淋巴瘤的真实世界对比研究：岐阜血液学研究组的一项多中心回顾性研究
Nobuhiko Nakamura,Nobuhiro Kanemura,Naoki Hayase et al.
Nobuhiko Nakamura et al.
Background Brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (BV-CHP) has demonstrated survival benefits over cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with CD30-positive peripheral T...
Allogeneic hematopoietic stem cell transplantation achieves complete response in refractory primary mediastinal large B-cell lymphoma after the failure of chemotherapy, CAR-T therapy, and PD-1 blockade [0.03%]
异基因造血干细胞移植可使难治性原发纵隔大B细胞淋巴瘤在化疗、CAR-T治疗和PD-1阻断失败后获得完全缓解
Tatsuya Suwabe,Yuri Furuyama,Ayako Kawakami et al.
Tatsuya Suwabe et al.
Primary mediastinal large B-cell lymphoma (PMBCL) typically responds to chemotherapy, and immunotherapies such as chimeric antigen receptor T-cell (CAR-T) therapy and the programmed cell death protein 1 (PD-1) inhibitor pembrolizumab have s...
Clinicopathological analysis of oral-cavity B-cell neoplasms: Comparison between non-immunosuppressive and immunosuppressive patients [0.03%]
口腔黏膜B细胞淋巴瘤的临床病理分析：非免疫抑制和免疫抑制患者的比较研究
Yuuki Ishii,Mebae Ichikawa,Yusuke Kondo et al.
Yuuki Ishii et al.
No comparative analysis of the infrequently occurring B-cell neoplasms (BCNs) in the oral cavity has yet been reported in patients with non-immunosuppressiveness or immunosuppressiveness. To identify any differences in clinicopathological f...
Real-world treatment outcomes of peripheral T-cell lymphoma in the era of molecular targeted therapy [0.03%]
分子靶向治疗时代外周T细胞淋巴瘤的现实世界治疗结局
Masuho Saburi,Takumi Nishikawa,Kuniaki Maehara et al.
Masuho Saburi et al.
Histiocytic sarcoma with a common clonal origin emerged after 33 years from B-cell precursor acute lymphoblastic leukemia [0.03%]
起病33年后B细胞前体急性淋巴细胞白血病克隆起源的朗格汉斯细胞组织细胞增生症₁₂
Misayo Miyake,Naoko Tsuyama,Yuki Togashi et al.
Misayo Miyake et al.
Histiocytic sarcoma (HS) is a rare, aggressive malignant neoplasm characterized by histiocytic features, frequently presenting in advanced clinical stages and associated with a poor prognosis. Although HS can occur sporadically or secondary...
Independent PML::RARA-positive acute promyelocytic leukemia arising during BCR::ABL1-positive chronic myeloid leukemia [0.03%]
独立的PML-RARA阳性急性早幼粒细胞白血病发生在BCR-ABL1阳性慢性粒细胞白血病期间
Takanori Yoshioka,Akira Kondo,Masayuki Matsuda et al.
Takanori Yoshioka et al.
Acute promyelocytic leukemia (APL) arising during the clinical course of BCR::ABL1-positive chronic myeloid leukemia (CML) is rare and may represent either promyelocytic blast phase or the emergence of an independent Philadelphia chromosome...
Synchronous diffuse large B-cell lymphoma and gynecological malignancy treated with paclitaxel and carboplatin: A report of two cases [0.03%]
帕利柔安联合卡铂治疗同步发生弥漫大B细胞淋巴瘤和妇科恶性肿瘤两例报告
Yuma Nato,Kana Miyazaki,Tsuyoshi Matsumoto et al.
Yuma Nato et al.
Diffuse large B-cell lymphoma (DLBCL) can occur at various sites and is rarely diagnosed as synchronous multiple primary malignancies. A treatment approach for this synchronous malignancy has not been established. Here, we report two cases ...